EDWARDS LARRY TODD (See Remarks) sold 2.1% of their position (3.69K shares) of ARCUTIS BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $92.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/3/2026ACC: 0001628280-26-014328
Officer· See Remarks
Since Feb 2026
+103.31K
Net shares
Net buyer
$92.8K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
107K acquired · 3.69K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+30K
Price / share
—
Trade value
—
% of position
20.2%
2/27/2026
148.87K→178.87K
Common Stock
Direct
Shares
−3.58K
Price / share
$25.16
Trade value
$90.18K
% of position
2.0%
3/2/2026
178.87K→175.28K
Common Stock
Direct
Shares
−103.00
Price / share
$25.91
Trade value
$2.67K
% of position
0.1%
3/2/2026
175.28K→175.18K
Total
Net shares
+26.31K
Net value
-$92.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2026 | A · Award | +30K | — | — | 20.2% | 148.87K | 178.87K |
| Common Stock Direct | 3/2/2026 | S · Sale | −3.58K | $25.16 | $90.18K | 2.0% | 178.87K | 175.28K |
| Common Stock Direct | 3/2/2026 | S · Sale | −103.00 | $25.91 | $2.67K | 0.1% | 175.28K | 175.18K |
| Total | +26.31K | -$92.85K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
77K shares
Shares
+77K
Strike price
26.97
Held after
77K
Exercisable
—
2/27/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock77K shares | 2/27/2026 | A · Award | +77K | 26.97 | — | 77K |